EMG
DXCM icon

ETF Managers Group’s DexCom DXCM Stock Holding History

ETF Managers Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$656K Buy
5,643
+84
+2% +$9.4K 0.02% 365
2022
Q4 		$630K Sell
5,559
-1,381
-20% -$152K 0.03% 286
2022
Q3 		$558K Buy
6,940
+1,784
+35% +$151K 0.02% 370
2022
Q2 		$389K Sell
5,156
-7,156
-58% -$653K 0.01% 556
2022
Q1 		$1.6M Sell
12,312
-49,240
-80% -$5.39M 0.03% 231
2021
Q4 		$8.33M Buy
61,552
+37,004
+151% +$5.32M 0.17% 138
2021
Q3 		$3.35M Sell
24,548
-25,600
-51% -$3.23M 0.06% 167
2021
Q2 		$5.35M Buy
50,148
+45,280
+930% +$4.35M 0.09% 144
2021
Q1 		$423K Buy
4,868
+756
+18% +$71K 0.01% 519
2020
Q4 		$373K Sell
4,112
-5,372
-57% -$480K 0.01% 477
2020
Q3 		$954K Buy
9,484
+1,272
+15% +$133K 0.03% 211
2020
Q2 		$818K Sell
8,212
-15,668
-66% -$1.4M 0.03% 205
2020
Q1 		$1.66M Sell
23,880
-3,868
-14% -$241K 0.08% 127
2019
Q4 		$1.5M Sell
27,748
-6,640
-19% -$315K 0.05% 145
2019
Q3 		$1.28M Buy
34,388
+27,720
+416% +$1.08M 0.05% 148
2019
Q2 		$243K Sell
6,668
-1,048
-14% -$32.9K 0.01% 304
2019
Q1 		$230K Buy
7,716
+604
+8% +$21.2K 0.01% 283
2018
Q4 		$213K Buy
7,112
+1,048
+17% +$33.2K 0.01% 286
2018
Q3 		$217K Buy
6,064
+632
+12% +$19.6K 0.01% 243
2018
Q2 		$55K Buy
5,432
+2,132
+65% +$45.2K ﹤0.01% 452
2018
Q1 		$61K Buy
3,300
+408
+14% +$6.03K ﹤0.01% 498
2017
Q4 		$42K Buy
2,892
+408
+16% +$5.3K ﹤0.01% 525
2017
Q3 		$30K Buy
2,484
+220
+10% +$3.89K ﹤0.01% 458
2017
Q2 		$41K Buy
+2,264
New +$41.8K ﹤0.01% 518

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

ETF Managers Group's DXCM Position: Q1 2023 in Review

ETF Managers Group increased its DexCom (DXCM) stake by 1.5% in Q1 2023, buying an estimated $9.4K and bringing the position to 5,643 shares worth $656K. The position accounts for 0.02% of the portfolio, ranked #365.

ETF Managers Group first reported a position in DXCM in Q2 2017 and has held it in 24 quarters since. The position peaked at $8.33M in Q4 2021. 905 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • ETF Managers Group held 5,643 shares of DexCom worth $656K as of Q1 2023.
  • ETF Managers Group bought 84 DexCom shares in Q1 2023, an estimated $9.4K.
  • DexCom made up 0.02% of ETF Managers Group's portfolio in Q1 2023, its #365 holding.
  • ETF Managers Group first reported a position in DexCom in Q2 2017 and has held it in 24 quarters since.
  • ETF Managers Group's DexCom position peaked at $8.33M in Q4 2021.
  • 905 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.